• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Generic Drug Switches – Anti-Depressants

Description: Initiate study of anti-depressant generic drug switches with Company X2


This key project has been retired as CDER has created new measures and key projects for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research.

Briefing Status: ON HOLD

Prior Briefing Status: ON TRACK

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

1. Finalize protocol

11/1/2009

Completed 11/30/2009

2. Initiate study

4/1/2010

Completed 4/1/2010

3. Complete study (1)

7/1/2011

Delayed

4. Release study report

11/1/2012

Delayed

Footnotes

  • (1) Completion of study will depend on ability to adequately recruit appropriate patients

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.